Astrotech (NASDAQ:ASTC – Get Free Report) and Prenetics Global (NASDAQ:PRE – Get Free Report) are both small-cap aerospace companies, but which is the superior business? We will contrast the two companies based on the strength of their earnings, profitability, risk, analyst recommendations, dividends, institutional ownership and valuation.
Earnings & Valuation
This table compares Astrotech and Prenetics Global’s revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Astrotech | $750,000.00 | 20.60 | -$9.64 million | ($6.76) | -1.34 |
| Prenetics Global | $21.74 million | 2.31 | -$62.72 million | ($4.45) | -1.24 |
Astrotech has higher earnings, but lower revenue than Prenetics Global. Astrotech is trading at a lower price-to-earnings ratio than Prenetics Global, indicating that it is currently the more affordable of the two stocks.
Risk and Volatility
Analyst Recommendations
This is a summary of current ratings and recommmendations for Astrotech and Prenetics Global, as reported by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Astrotech | 0 | 0 | 0 | 0 | N/A |
| Prenetics Global | 0 | 0 | 1 | 0 | 3.00 |
Prenetics Global has a consensus target price of $9.00, suggesting a potential upside of 63.64%. Given Prenetics Global’s higher possible upside, analysts plainly believe Prenetics Global is more favorable than Astrotech.
Profitability
This table compares Astrotech and Prenetics Global’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Astrotech | -550.25% | -26.78% | -25.16% |
| Prenetics Global | -282.96% | -10.76% | -8.79% |
Insider and Institutional Ownership
24.4% of Astrotech shares are owned by institutional investors. Comparatively, 25.0% of Prenetics Global shares are owned by institutional investors. 11.5% of Astrotech shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.
Summary
Prenetics Global beats Astrotech on 10 of the 13 factors compared between the two stocks.
About Astrotech
Astrotech Corporation operates as a mass spectrometry company worldwide. It owns and licenses the intellectual property related to the Astrotech Mass Spectrometer Technology, a platform mass spectrometry technology. The company also develops TRACER 1000, a mass spectrometer-based explosive trace detector to replace the explosives trace detectors used at airports, cargo and other secured facilities, and borders. In addition, it develops AgLAB-1000, a mass spectrometer for use in the hemp and cannabis market. Further, the company develops BreathTest-1000, a breath analysis tool to screen for volatile organic compound metabolites found in a person's breath. The company was formerly known as SPACEHAB, Inc. and changed its name to Astrotech Corporation in 2009. The company was incorporated in 1984 and is based in Austin, Texas.
About Prenetics Global
Prenetics Global Limited, a genomics-driven health sciences company, engages in revolutionizing prevention, early detection, and treatment. It offers CircleDNA, a prevention arm that uses whole exome sequencing to offer comprehensive consumer DNA test. The company also, through its joint venture, Insighta, engages in pioneering multi-cancer early detection technologies. In addition, the company, through its equity interests in ACT Genomics Holdings Company Limited, is involved in genomic profiling of solid tumors through ACTOnco. Prenetics Global Limited was founded in 2007 and is based in Quarry Bay, Hong Kong.
Receive News & Ratings for Astrotech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astrotech and related companies with MarketBeat.com's FREE daily email newsletter.
